France In Vitro Diagnostics Market Growth, Size, Trends Analysis- By Test Type, By Technology, By Product Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

France In Vitro Diagnostics Market Introduction and Overview

According to SPER Market Research, 'France In Vitro Diagnostics Market Size- By Test Type, By Technology, By Product Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the France In Vitro Diagnostics Market is estimated to reach USD 8424.36 million by 2033 with a CAGR of 6.45%.

In vitro diagnostics (IVD) refers to tests or analyses performed on human body samples, such as blood or tissue samples. The phrase in vitro, signifies that test tubes or petri dishes are frequently utilized in these operations. IVD is non-invasive, and while certain varieties can be used in a hospital or other official environment, others can be used at home by people.

The French in vitro diagnostics (IVD) industry saw tremendous development as a result of the COVID-19 epidemic, which raised demand for diagnostic tests. The urgent need to identify COVID-19 caused a spike in point-of-care and molecular diagnostics, which increased market revenues. To accommodate the demand for testing, laboratories increased their capacity and swiftly developed and certified new technologies.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Test Type, By Technology, By Products Type, By Application, By End User.

Regions covered Eastern, Western, Northern, Southern.

Companies Covered Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation, Qiagen N.V, Johnson & Johnson, Bayer AG, Bio-Rad Laboratories.

France In-Vitro Diagnostics Segmentation:

By Test Type: Based on the Test Type, France In-Vitro Diagnostics Market is segmented as; ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays, In Situ Hybridisation, Transcription Mediated Amplification, Colorimetric Immunoassay, Radioimmunoassay, Sequencing, Isothermal Nucleic Acid Amplification Technology, Others.

By Technology: Based on the Technology, France In-Vitro Diagnostics Market is segmented as; Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Others.

By Products Type: Based on the Products Type, France In-Vitro Diagnostics Market is segmented as; Services, Instruments, Reagent.

By Application: Based on the Application, France In-Vitro Diagnostics Market is segmented as; Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications.

Product Code: HLCA2482

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the France In Vitro Diagnostics Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. France In Vitro Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in France In Vitro Diagnostics Market

7. France In Vitro Diagnostics Market, By Test Type (USD Million) 2020-2033

7.1. France In Vitro Diagnostics Market Size, Share and Forecast, By Test Type, 2020-2026
7.2. France In Vitro Diagnostics Market Size, Share and Forecast, By Test Type, 2027-2033
7.3. ELISA & CLIA
7.4. PCR
7.5. Rapid Test
7.6. Fluorescence Immunoassays (FIA)
7.7. In Situ Hybridization
7.8. Transcription Mediated Amplification
7.9. Colorimetric Immunoassay
7.10. Radioimmunoassay (RIA)
7.11. Sequencing
7.12. Isothermal Nucleic Acid Amplification Technology
7.13. Others

8. France In Vitro Diagnostics Market, By Technology (USD Million) 2020-2033

8.1. France In Vitro Diagnostics Market Size, Share and Forecast, By Technology, 2020-2026
8.2. France In Vitro Diagnostics Market Size, Share and Forecast, By Technology, 2027-2033
8.3. Immunoassay
8.4. Clinical Chemistry
8.5. Molecular Diagnostics/Genetics
8.6. Hematology
8.7. Microbiology
8.8. Coagulation
8.9. Others

9. France In Vitro Diagnostics Market, By Product Type (USD Million) 2020-2033

9.1. France In Vitro Diagnostics Market Size, Share and Forecast, By Product Type, 2020-2026
9.2. France In Vitro Diagnostics Market Size, Share and Forecast, By Product Type, 2027-2033
9.3. Services
9.4. Instruments
9.5. Reagents

10. France In Vitro Diagnostics Market, By Application (USD Million) 2020-2033

10.1. France In Vitro Diagnostics Market Size, Share and Forecast, By Application, 2020-2026
10.2. France In Vitro Diagnostics Market Size, Share and Forecast, By Application, 2027-2033
10.3. Infectious Disease
10.4. Diabetes
10.5. Cardiology
10.6. Oncology
10.7. Nephrology
10.8. Autoimmune Diseases
10.9. Drug Testing
10.10. Other Applications

11. France In Vitro Diagnostics Market, By End User, 2020-2033 (USD Million)

11.1. France In Vitro Diagnostics Market Size, Share and Forecast, By End User, 2020-2026
11.2. France In Vitro Diagnostics Market Size, Share and Forecast, By End User, 2027-2033
11.3. Hospitals
11.4. Laboratories
11.5. Home a€" Care
11.6. Others

12. France In Vitro Diagnostics Market, By Region, 2020-2033 (USD Million)

12.1. France In Vitro Diagnostics Market Size and Market Share By Region (2020-2026)
12.2. France In Vitro Diagnostics Market Size and Market Share By Region (2027-2033)
12.3. Eastern
12.4. Western
12.5. Northern
12.6. Southern

13. Company Profile

13.1. Roche Diagnostics
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Abbott Diagnostics
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. Siemens Healthineers
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Danaher Corporation
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Thermo Fisher Scientific
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Sysmex Corporation
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Qiagen N.V
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. Johnson & Johnson
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Bayer AG
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Bio-Rad Laboratories
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
13.11. Others